Leading Infection Prevention Company, Schülke to Join ATHOS Consortium Following EQT Private Equity’s Strategic Ownership

Leading Infection Prevention Company, Schülke to Join ATHOS Consortium Following EQT Private Equity’s Strategic Ownership

(IN BRIEF) EQT Private Equity has agreed to sell Schülke, a provider of infection prevention solutions for the healthcare industry, to the ATHOS Consortium. Under EQT’s ownership, Schülke focused on the healthcare market, expanded into new geographies, and became a sustainability leader. The ATHOS Consortium, led by a Munich-based family office, will acquire Schülke. The transaction is expected to close in Q4 2023.

(PRESS RELEASE) STOCKHOLM, 8-Aug-2023 — /EuropaWire/ — EQT Private Equity has agreed to sell Schülke, a key player in infection prevention and treatment solutions for the healthcare industry, to the ATHOS Consortium. After acquiring the company in 2020, EQT Private Equity successfully repositioned Schülke to focus solely on the healthcare and life science market, expanded into new geographies, and implemented a customer-centric sustainability strategy.

Schülke, headquartered in Norderstedt, Germany, supplies high-quality disinfectants and antisepsis products to hospitals and healthcare institutions worldwide. Under EQT’s ownership, Schülke experienced impressive growth, delivering double-digit annual revenue growth and almost doubling EBITDA in its core healthcare business.

The partnership with EQT Private Equity enabled Schülke to become a sustainability leader in the industry. The company launched a pioneering green hospital-grade product line, transitioned to nearly 100% green electricity, and committed to reducing greenhouse gas emissions by up to 40% by 2030.

The ATHOS Consortium, led by a Munich-based single family office, along with co-investors like Bitburger Holding, will acquire Schülke from EQT Private Equity. The transaction is expected to close in Q4 2023, subject to regulatory approvals.

About EQT:
EQT is a global investment organization with EUR 126 billion in assets under management, supporting portfolio companies in Europe, Asia-Pacific, and the Americas for sustainable growth, operational excellence, and market leadership.

About Schülke:
Schülke, with almost 135 years of experience, specializes in providing infection prevention and treatment solutions. With a commitment to protecting lives worldwide, the company offers a wide range of high-quality and innovative products for healthcare, life sciences, direct patient care, and more.

About ATHOS:
ATHOS is a Munich-based single family office investing in healthcare and life sciences, focusing on science-driven companies with a value-based approach.

Media contacts:

EQT Press Office
press@eqtpartners.com
+46 8 506 55 334

SOURCE: